2m 2m 2m 2m 2m 2m 2m
TENAYA THERAP (TNYA)
NASDAQ
$0.71+$0.010 (+1.39%)
Price as of Aug 21, 2026 7:54 PM EDT- $156.4MMarket Cap
- -38.29%1-Year Change
- BiotechnologyIndustry
TENAYA THERAP (TNYA)
$0.71+$0.010 (+1.39%)
TNYA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.70 | ||
Change | +$0.007 (+0.98%) | ||
Open | $0.69 | ||
High | $0.72 | ||
Low | $0.69 | ||
Previous Close | $0.69 | ||
Volume | 1,154,427 | ||
30-Day Average Volume | 1,963,244 | ||
1-Week Change | -4.23% | ||
1-Month Change | -15.44% | ||
1-Year Change | -38.29% | ||
3-Year Change | -83.24% | ||
5-Year Change | -96.92% | ||
Fundamentals | |||
Shares Outstanding | 224.2M | ||
Total Assets | $93.5M | ||
Market Cap | $156.4M | ||
Enterprise Value | $78.3M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$43.4M | ||
Free Cash Flow | -$3.7M | ||
EBIT | -$43.4M | ||
EBITDA | -$41.7M | ||
Net Working Capital | $67.0M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 71 | ||
P/B | 2 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue